Drug Stock Hug Flat-line; Mannkind Dips
Hub of the Universe — Both the biotechnology and pharmaceutical bench marks squeezed the flat logical argument early Mon, with the Curb Pharmaceutical Index up 0.1% at 300.1 and the American Stock Exchange Biotech Index down 0.1% at 767.8. Shares of Mannkind Corporation. struck down 6% to USD 2.35. The stock has been on the shoes since former rival Pfizer INC. proclaimed earliest this days that medical information exhibited a smattering of exploiters of its inhaled insulin product Exubera had got undertaken lung malignant neoplastic disease. Mannkind is too germinating an inhaled insulin product.
Comments
Leave a Reply